SCHEMBL6505693

SCHEMBL6505693

c1ccc(Oc2cccc(CN3CCCNCC3)c2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.63
KDM4E B2RXH2 3/20 0.63
TDP1 Q9NUW8 2/20 0.63
HPGD P15428 1/20 0.63
HTT P42858 1/20 0.63
SIGMAR1 Q99720 2/20 0.58
TRPV6 Q9H1D0 1/20 0.57
CHRM3 P20309 1/20 0.57
CXCR4 P61073 6/20 0.55
LMNA P02545 1/20 0.55
GAA P10253 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MEN1 O00255 1/20 0.54
CHRM2 P08172 1/20 0.54
CHRM1 P11229 1/20 0.54
ADRA2C P18825 1/20 0.54
CCR2 P41597 1/20 0.54
CXCL12 P48061 1/20 0.54
BLM P54132 1/20 0.54
KMT2A Q03164 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7649187 0.94 ALDH1A1 (0.69) ALDH1A1KDM4ETDP1HPGDHTT
SCHEMBL6499571 0.87 ALDH1A1 (0.75) ALDH1A1KDM4ETDP1HPGDHTT
SCHEMBL6496864 0.86 ALDH1A1 (0.73) ALDH1A1KDM4ETDP1HPGDHTT
SCHEMBL17696031 0.85 SIGMAR1 (0.65) ALDH1A1KDM4ETDP1SIGMAR1CHRM3
Hydrochloric Acid SCHEMBL7424646 0.84 SIGMAR1 (0.63) ALDH1A1KDM4ETDP1SIGMAR1CHRM3
Hydrochloric Acid SCHEMBL2451705 0.83 ALDH1A1 (0.70) ALDH1A1KDM4ETDP1HPGDHTT
SCHEMBL255099 0.82 SIGMAR1 (0.85) ALDH1A1TDP1SIGMAR1CXCR4MEN1
SCHEMBL10316935 0.82 SIGMAR1 (0.85) ALDH1A1TDP1SIGMAR1CXCR4MEN1
SCHEMBL13743319 0.82 ALDH1A1 (0.70) ALDH1A1KDM4ETDP1HPGDHTT
SCHEMBL674945 0.81 CXCR4 (0.75) TDP1SIGMAR1CXCR4SMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143372-A1 Compounds, pharmaceutical compositions and methods of use therefor MILLENNIUM PHARMACEUTICALS, INC. 2005-06-30 US disclosed
US-20050080113-A1 Medicinal compositions TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-04-14 US disclosed
WO-2003037271-A2 COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREFOR MILLENNIUM PHARMACEUTICALS,INC. (US) 2003-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050080113-A1 Medicinal compositions TNF, TRAF6, MMP8 ALDH1A1 3345/4885KDM4E 4034/4885TDP1 3398/4885
US-20050143372-A1 Compounds, pharmaceutical compositions and methods of use therefor CCR8, CCL11, CCR5 ALDH1A1 1071/4885KDM4E 4617/4885TDP1 3425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.